Showing 591-600 of 3402 results for "".
What's Old Is New
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/old-new-2017/18512/Besides new fillers and better device-based combinations, Joel L. Cohen, MD says that 2017 will bring new data on some existing interventions that may improve aesthetic procedures. Watch the video memo now.A Change in Technology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/technology-2017/18513/From innovations in fillers to enhancements of energy-based devices, core physicians will find new ways to optimize outcomes in 2017, says Suneel Chilukuri, MD in this video memo.Consolidation or Competition: The Road to Optimization
https://practicaldermatology.com/topics/practice-management/consolidation-or-competition-the-road-to-optimization/18769/What's next for the dermatology/aesthetics industry? Joel Schlessinger, MD, founder of Cosmetic Surgery Forum, describes what has taken place in the aesthetic space and predicts what's next, especially in the laser/device space.Promising Therapies on the Atopic Dermatitis Horizon
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37178/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, previews important potential developments in the atopic dermatitis pipelineISDPA: Dr. Bhatia on JAK Inhibitors
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-jak-inhibitors/27064/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about his presentation on JAK inhibitors at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Secondary Prurigo Nodularis and Psoriasis
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37168/Raja Sivamani, MD, MS, AP, an integrative dermatologist and Adjunct Associate Professor of Clinical Dermatology at the University of California, Davis, highlights the importance of being vigilant for prurigo nodularis not only in atopic dermatitis patients but also in psoriasis patients.Quality of Life and the Mental Toll of Itch
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37179/Justin Marson, MD, Chief Resident 2024-25 in the Department of Dermatology at SUNY Downstate Health Science University, addresses the psychological impact of itch and how it can affect a patient’s overall quality of life.The Role of Topical Steroids in AD
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37138/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the role of topical steroids in treating atopic dermatitis.SDPA: Medical Director Dr. Hilary Baldwin on Conference Planning Process
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-medical-director-dr-hilary-baldwin-conference-planning-process/29507/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with conference medical director Hilary Baldwin, MD. Dr. Baldwin shares insights on the process of planning SDPA.DermWire TV Extra: Dr. Bunick on BPO Study
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-bunick-bpo-study/29165/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the new Journal of Investigative Dermatology article he co-authored, "Evaluation of Benzene Presence and Formulation in Benzoyl Peroxide Drug Products."